Back to Newsroom
Back to Newsroom

Calian Reports Record Revenue for Year Ended September 30, 2020

Tuesday, 24 November 2020 04:30 PM

Calian Group Ltd.

Topic:
Earnings

Annual Revenue Grows 26%, including Fourth-Quarter Increase of 35%

OTTAWA, ON / ACCESSWIRE / November 24, 2020 / Calian Group Ltd. (TSX:CGY), deliverer of trusted solutions across advanced technologies, health, learning & information technology segments, today released its annual results for the year ended September 30, 2020.

Calian Group Ltd. (the "Company") reported revenues for the quarter of $123 million, representing a 35% increase from the $90.9 million reported in the same quarter of the previous year. For the year ended September 30, 2020, the Company reported revenues of $432 million, a 26% increase from the $343 million in the prior year.

Fourth quarter and full year 2020 highlights:

  • Record quarterly revenue for the ninth consecutive quarter
  • Quarterly revenue of $123 million, an increase of 35% from the same quarter of the previous year
  • Annual revenue of $432 million, an increase of 26% from the previous year
  • Adjusted EBITDA(1) of 9.2 million for the fourth quarter, an increase of 13% from the previous year
  • Adjusted EBITDA(1) of $36.8 for the fiscal year 2020, an increase of 36%
  • 76th consecutive profitable quarter
  • New contract signings of $111 million in fourth quarter
  • Dividend of $0.28 per share

"I am pleased to report Calian's record year on multiple fronts. Revenue for the year was an all-time high for the Company at $432M. Organic growth was strong at 21% in the twelve-month period, led by our Health and Advanced Technologies segments. Our profitable growth objective was also evident as we grew EBITDA by 36% thanks to increased volume and scaling our business efficiently," said Kevin Ford, President and CEO. "We completed four acquisitions in 2020, three of them in new market verticals in which Calian did not previously participate. M&A has played an important role in all four of our segments by bringing in new customers and new technologies aligned to our growth strategy."

Adjusted EBITDA(1) for the fourth quarter was $9.2 million, an increase of 14% from $8.1 million in the same quarter of the previous year. For the year ended September 30, 2020, Adjusted EBITDA(1) was $36.8 million, a 36% increase compared to the $27.1 million in the same period of the previous year.

Adjusted net profit,(1) which excludes non-cash items related to recent acquisitions, was $5.6 million for the quarter; this compares to $5.7 million in the same period of the previous year. For the year ended September 30, 2020, Adjusted net profit (1) was $23.5 million, which increased by 24% from the $19.0 million in the same period of the previous year.

Net profit for the fourth quarter was $6.9 million, and $20.4 million the year ended September 30, 2020, representing an increase of 2% from the $20.0 million in the same period of the previous year.

"Our ninth consecutive record revenue quarter capped a year in which we recorded our highest ever Revenue, EBITDA and Net Income," stated Patrick Houston, CFO. "Our focus on profitable growth was seen with 26% revenue growth and EBITDA growth of 36%. These results were accomplished in a rapidly changing environment due to COVID-19 which necessitated our team of dedicated professionals in each of our segments to adapt quickly and continue to deliver essential products and services."

"COVID-19 has resulted in a rapidly changing business environment, but our teams continued to adapt and find news ways to deliver our services which were deemed essential in all of our segments," said Kevin Ford. "I would like to thank all frontline health and essential service workers for their dedication and courage during this very challenging, ongoing public health crisis. Our own dedicated staff at Calian have been out there delivering essential services alongside other frontline health workers, Canadian Armed Forces members and many other service workers. From all of us at Calian, we offer our deepest appreciation for your service."

"I would like to also officially welcome the Tallysman team to Calian, an acquisition we completed in the last month of the quarter. Offering the most extensive range of Global Navigation Satellite System, Iridium and Globalstar antennas, Tallysman excels at supporting the requirements of any project, anywhere in the world. We look forward to their continued innovation as a global leader and are excited to have them on the Calian team" stated Ford.

"Looking forward, our initial guidance demonstrates our confidence in Calian maintaining a growth profile in this new fiscal year. I believe our diversified segments with a mix of domestic and global customers positions us well to navigate through the challenges created by COVID while continuing to execute our growth strategy," continued Ford.

(1) Caution regarding non-GAAP measures:

This press release is based on reported earnings in accordance with IFRS. Reference to generally accepted accounting principles (GAAP) means IFRS, unless indicated otherwise. This press release is also based on non-GAAP financial measures including EBITDA, adjusted net profit and adjusted net profit per share. These non-GAAP measures do not have a standardized meaning prescribed by IFRS; therefore, others using these terms may calculate them differently. Management believes that providing certain non-GAAP performance measures, in addition to IFRS measures, provides users of our financial reports with enhanced understanding of our results and related trends and increases transparency and clarity into the core results of our business. Refer to the MD&A for definitions of these metrics and reconciliations to the most comparable IFRS measures.

GUIDANCE

 
  Current Guidance  
 
  Low     High  
Revenue
  $ 450,000     $ 490,000  
 
               
Adjusted EBITDA
  $ 38,500     $ 42,000  
Adjusted net profit
  $ 25,200     $ 28,300  

About Calian

Calian employs over 4,400 people in its delivery of diverse products and solutions for private sector, government and defence customers in North American and global markets. The Company's diverse capabilities are delivered through four segments: Advanced Technologies, Health, Learning and Information Technology. The Advanced Technologies segment provides innovative products, technologies and manufacturing services and solutions for the space, communications, defence, nuclear, government and agriculture sectors. The Health segment manages a network of more than 1,800 health care professionals delivering primary care and occupational health services to public and private sector clients across Canada. Learning is a trusted provider of emergency management, consulting and specialized training services and solutions for the Canadian Armed Forces and clients in the defence, health, energy and other sectors. The Information Technology segment supports public- and private-sector customer requirements for subject matter expertise in the delivery of complex IT and cyber security solutions. Headquartered in Ottawa, the Company's offices and projects span Canada and international markets.

For further information, please visit our website at www.calian.com, or contact us at [email protected].

Kevin Ford
President and Chief Executive Officer
613-599-8600

Patrick Houston
Chief Financial Officer
613-599-8600

Media inquiries:
613-599-8600 x 2298

DISCLAIMER

Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as "intend," "anticipate," "believe," "estimate," "expect" or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company's most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.

Calian Group Ltd. Consolidated Statements of Financial Position
As at September 30, 2020 and 2019
(Canadian dollars in thousands, except per share data)

 
  September 30,     September 30,  
 
  2020     2019  
ASSETS
           
CURRENT ASSETS
           
Cash and cash equivalents
  $ 24,235     $ 17,135  
Accounts receivable
    81,109       63,977  
Work in process
    84,132       39,221  
Inventory
    6,095       3,147  
Prepaid expenses
    6,707       5,403  
Derivative assets
    358       96  
Total current assets
    202,636       128,979  
NON-CURRENT ASSETS
               
Capitalized research and development
    3,924       3,216  
Equipment
    11,655       10,965  
Application software
    3,092       1,013  
Right of use asset
    17,595       -  
Investment and loan receivable
    670       452  
Acquired intangible assets
    36,191       16,699  
Goodwill
    55,290       33,702  
Total non-current assets
    128,417       66,047  
TOTAL ASSETS
  $ 331,053     $ 195,026  
LIABILITIES AND SHAREHOLDERS' EQUITY
               
CURRENT LIABILITIES
               
Line of Credit
  $ -     $ 13,000  
Accounts payables and accrued liabilities
    72,007       45,058  
Contingent earn-out
    3,251       800  
Provisions
    1,038       1,129  
Unearned contract revenue
    13,435       8,778  
Derivative liabilities
    152       143  
Lease obligations
    2,790       -  
Total current liabilities
    92,673       68,908  
NON-CURRENT LIABILITIES
               
Lease obligations
    16,800       -  
Contingent earn-out
    11,913       5,519  
Deferred tax liabilities
    9,261       5,525  
Total non-current liabilities
    37,974       11,044  
TOTAL LIABILITIES
    130,647       79,952  
 
               
SHAREHOLDERS' EQUITY
               
Issued capital
    107,931       32,515  
Contributed surplus
    2,002       1,817  
Retained earnings
    92,030       81,608  
Accumulated other comprehensive income (loss)
    (1,557 )     (866 )
TOTAL SHAREHOLDERS' EQUITY
    200,406       115,074  
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
  $ 331,053     $ 195,026  
Number of common shares issued and outstanding
    9,760,032       7,929,238  

Calian Group Ltd. Consolidated Statements of Net Profit
For the years ended September 30, 2020 and 2019
(Canadian dollars in thousands, except per share data)

 
 
Three months ended
September 30,
   
Year ended
September 30,
 
    2020     2019     2020     2019  
Revenue
                       
Advanced Technologies
  $ 37,570     $ 31,437     $ 153,382     $ 109,697  
Health
    56,848       31,286       163,035       115,718  
Learning
    14,282       13,983       57,834       63,098  
Information Technology
    14,357       14,208       58,069       54,531  
Total Revenue
    123,057       90,914       432,320       343,044  
Cost of revenues
    100,190       70,571       343,164       268,387  
Gross profit
    22,867       20,343       89,156       74,657  
Selling and marketing
    3,028       2,769       12,336       10,499  
General and administration
    9,978       8,990       38,012       35,592  
Research and development
    658       436       1,998       1,420  
Profit before under noted items
    9,203       8,148       36,810       27,146  
Depreciation of equipment, application software and research and development
    969       622       2,976       2,220  
Depreciation of right of use asset
    734       -       2,771       -  
Amortization of acquired intangible assets
    1,684       1,460       5,166       3,168  
Other changes in fair value
    -       -       (101 )     -  
Changes in fair value related to contingent earn-out
    (2,772 )     (4,225 )     (1,882 )     (4,149 )
Profit before interest and income tax expense
    8,588       10,291       27,880       25,907  
Lease obligations interest expense
    123       -       475       -  
Interest expense (income)
    19       50       185       36  
Profit before income tax expense
    8,446       10,241       27,220       25,871  
Income tax expense - current
    2,122       1,982       8,171       6,318  
Income tax expense (recovery) - deferred
    (562 )     (217 )     (1,311 )     (439 )
Total income tax expense
    1,560       1,765       6,860       5,879  
NET PROFIT
  $ 6,886     $ 8,476     $ 20,360     $ 19,992  
Net profit per share:
                               
Basic
  $ 0.70     $ 1.08     $ 2.25     $ 2.55  
Diluted
  $ 0.70     $ 1.08     $ 2.23     $ 2.54  

 

Calian Group Ltd. Consolidated Statements of Cash Flows
For the years ended September 30, 2020 and 2019
(Canadian dollars in thousands, except per share data)

 
  Three months ended
September 30,
   
Year ended
September 30,
 
 
  2020     2019     2020     2019  
CASH FLOWS GENERATED FROM OPERATING ACTIVITIES
                       
Net profit
  $ 6,886     $ 8,476     $ 20,360     $ 19,992  
Items not affecting cash:
                               
Interest expense (income)
    19       50       185       36  
Changes in fair value related to contingent earn-out
    (2,772 )     (4,225 )     (1,882 )     (4,149 )
Lease interest expense
    123       -       475       -  
Income tax expense
    1,560       1,765       6,860       5,879  
Employee share purchase plan expense
    78       37       199       173  
Share based compensation expense
    279       322       1,163       1,182  
Depreciation and amortization
    3,387       2,082       10,913       5,388  
Other changes in fair value
    -       -       (101 )     -  
 
    9,560       8,507       38,172       28,501  
Change in non-cash working capital
                               
Accounts receivable
    7,256       3,140       (11,676 )     6,334  
Work in process
    (8,508 )     (12,501 )     (44,911 )     (20,973 )
Prepaid expenses
    1,225       1,173       (1,271 )     (1,395 )
Inventory
    (133 )     (85 )     (328 )     1,216  
Accounts payable and accrued liabilities
    2,233       4,479       17,251       8,167  
Unearned contract revenue
    (12,314 )     (2,587 )     4,501       (1,806 )
 
    (681 )     2,126       1,738       20,044  
Interest received (paid)
    (142 )     (50 )     (678 )     (127 )
Income tax recovered (paid)
    1,059       (1,409 )     (3,813 )     (6,384 )
 
    236       667       (2,753 )     13,533  
CASH FLOWS GENERATED FROM FINANCING ACTIVITIES
                               
Issuance of common shares net of costs
    1,589       366       70,488       3,316  
Dividends
    (2,747 )     (2,235 )     (9,938 )     (8,803 )
Draw (repayment) on line of credit
    -       1,000       (13,000 )     13,000  
Share repurchase
    -       -       -       (118 )
Payment of lease obligations
    (656 )     -       (2,508 )     -  
 
    (1,814 )     (869 )     45,042       7,395  
CASH FLOWS USED IN INVESTING ACTIVITIES
                               
Investments and loan receivable
    -       -       (100 )     -  
Business acquisitions
    (18,855 )     -       (29,288 )     (20,849 )
Capitalized research and development
    (107 )     (96 )     (1,227 )     (1,768 )
Equipment and application software
    (1,521 )     (552 )     (4,574 )     (3,018 )
 
    (20,483 )     (648 )     (35,189 )     (25,635 )
 
                               
NET CASH (OUTFLOW) INFLOW
  $ (22,061 )   $ (850 )   $ 7,100     $ (4,707 )
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
  $ 46,296     $ 17,985     $ 17,135     $ 21,842  
CASH AND CASH EQUIVALENTS, END OF PERIOD
  $ 24,235     $ 17,135     $ 24,235     $ 17,135  

Reconciliation of non-GAAP measures to most comparable IFRS measures

These non-GAAP measures are mainly derived from the consolidated financial statements, but do not have a standardized meaning prescribed by IFRS; therefore, others using these terms may calculate them differently. The exclusion of certain items from non-GAAP performance measures does not imply that these are necessarily nonrecurring. From time to time, we may exclude additional items if we believe doing so would result in a more transparent and comparable disclosure. Other entities may define the above measures differently than we do. In those cases, it may be difficult to use similarly named non-GAAP measures of other entities to compare performance of those entities to the Company's performance.

Management believes that providing certain non-GAAP performance measures, in addition to IFRS measures, provides users of the Company's financial reports with enhanced understanding of the Company's results and related trends and increases transparency and clarity into the core results of the business. Adjusted EBITDA excludes items that do not reflect, in our opinion, the Company's core performance and helps users of our MD&A to better analyze our results, enabling comparability of our results from one period to another.

The weighted average shares outstanding over the period presented increased largely because of equity financing in the twelve-month period ended September 30, 2020. The equity financing closed in February 2020 resulted in an additional 1,568,600 common shares being issued. Along with other equity transactions throughout the year, the total common shares outstanding grew from 7,929,238 at September 30, 2019 to 9,760,032 as at September 30, 2020. The fully diluted weighted average shares outstanding increased to 9,855,357 for the three-month period and 9,104,498 for the twelve-month period ended September 30, 2020 when compared to 7,965,442 and 7,863,361, respectively, for the same periods of the previous year.

Adjusted EBITDA

 
  Three months ended     Year ended  
 
  September 30,
2020
   
September 30,
2019(1)
    September 30,
2020
    September 30,
2019
(1)
 
Net profit
  $ 6,886     $ 8,476     $ 20,360     $ 19,992  
Depreciation of equipment and application software
    969       622       2,976       2,220  
Depreciation of right of use asset
    734       -       2,771       -  
Amortization of acquired intangible assets
    1,684       1,460       5,166       3,168  
Lease interest expense
    123       -       475       -  
Changes in fair value related to contingent earn-out
    (2,772 )     (4,225 )     (1,882 )     (4,149 )
Deemed compensation
    -       -       -       -  
Interest expense (income)
    19       50       185       36  
Other changes in fair value
    -       -       (101 )     -  
Income tax
    1,560       1,765       6,860       5,879  
Adjusted EBITDA
  $ 9,203     $ 8,148     $ 36,810     $ 27,146  

(1) No restatement performed in Fiscal 2019 figures due to the entity applying the modified retrospective approach on implementation of IFRS 16 which occurred in fiscal 2020.

Adjusted net profit and adjusted EPS

 
  Three months ended     Year ended  
 
  September 30,
2020
   
September 30,
2019(1)
    September 30,
2020
    September 30,
2019
(1)
 
Net profit
  $ 6,886     $ 8,476     $ 20,360     $ 19,992  
Other changes in fair value
    -       -       (101 )     -  
Changes in fair value related to contingent earn-out
    (2,772 )     (4,225 )     (1,882 )     (4,149 )
Deemed compensation
    -       -       -       -  
Amortization of intangibles
    1,684       1,460       5,166       3,168  
Adjusted net profit
    5,798       5,711     $ 23,543     $ 19,011  
Weighted average number of common shares basic
    9,732,754       7,915,071       9,044,588       7,843,265  
Adjusted EPS Basic
    0.60       0.74       2.60       2.43  
Adjusted EPS Diluted
    0.59       0.73       2.59       2.41  

(2) No restatement performed in Fiscal 2019 figures due to the entity applying the modified retrospective approach on implementation of IFRS 16 which occurred in fiscal 2020.

The Company uses adjusted net profit and adjusted earnings per share, which remove the impact of our acquisition amortization and gains, resulting in accounting for acquisitions and changes in fair value to measure our performance. These measurements better align the reporting of our results and improve comparability against our peers. We believe that securities analysts, investors and other interested parties frequently use non-GAAP measures in the evaluation of issuers. Management also uses non-GAAP measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability to meet our capital expenditure and working capital requirements. Adjusted profit and adjusted earnings per share are not recognized, defined or standardized measures under the International Financial Reporting Standards. Our definition of adjusted profit and adjusted earnings per share will likely differ from that used by other companies (including our peers) and therefore comparability may be limited. Non-GAAP measures should not be considered a substitute for or be considered in isolation from measures prepared in accordance with International Financial Reporting Standards. Investors are encouraged to review our financial statements and disclosures in their entirety and are cautioned not to put undue reliance on non-GAAP measures and view them in conjunction with the most comparable International Financial Reporting Standards financial measures. The Company has reconciled adjusted profit to the most comparable International Financial Reporting Standards financial measure as shown above.

SOURCE: Calian Group Ltd.

Topic:
Earnings
Back to newsroom
Back to Newsroom
Share by: